New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
10:00 EDTSONS, NAO, FUEL, TTGT, PTCT, GLNG, CHEF, MOBL, EBMT, MDCA, CLGXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Chef's Warehouse (CHEF) initiated with a Market Perform at BMO Capital... CoreLogic (CLGX) initiated with a Buy at Monness Crespi... Eagle Bancorp (EBMT) initiated with an Outperform at Fig Partners... Golar LNG (GLNG) initiated with a Buy at BofA/Merrill... MDC Partners (MDCA) initiated with an Overweight at Evercore... MobileIron (MOBL) initiated with a Buy at Deutsche Bank... Nordic American Offshore (NAO) initiated with an Overweight at Morgan Stanley... PTC Therapeutics (PTCT) initiated with a Buy at Roth Capital... Rocket Fuel (FUEL) initiated with a Market Perform at Wells Fargo... Sonus Networks (SONS) initiated with an Outperform at Pacific Crest... TechTarget (TTGT) initiated with a Buy at Craig-Hallum.
News For CHEF;CLGX;EBMT;GLNG;MDCA;MOBL;NAO;PTCT;FUEL;SONS;TTGT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
11:32 EDTPTCTOptions with increasing implied volatility: PTCT ARIA
Subscribe for More Information
August 28, 2015
11:04 EDTPTCTOptions with increasing implied volatility
Subscribe for More Information
10:02 EDTGLNGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADP (ADP) upgraded to Outperform from Market Perform at William Blair... ASML (ASML) upgraded to Buy from Hold at Berenberg... Abercrombie & Fitch (ANF) upgraded on Hollister fundamentals at RBC Capital... Akamai (AKAM) upgraded to Outperform from Market Perform at JMP Securities... Ares Capital (ARCC) upgraded to Outperform from Market Perform at Raymond James... Banco Santander (SAN) upgraded on valuation at Deutsche Bank... CIBC (CM) upgraded to Neutral from Underperform at Credit Suisse... Canon (CAJ) upgraded to Hold from Sell at Deutsche Bank... Citi (C) upgraded to Buy from Neutral at Guggenheim... Ctrip.com (CTRP) upgraded to Buy from Hold at Stifel... El Pollo Loco (LOCO) upgraded at Stifel... Genomic Health (GHDX) upgraded to Market Perform from Underperform at Raymond James... Golar LNG (GLNG) upgraded on valuation, upcoming project completion at Stifel... Habit Restaurants (HABT) upgraded to Buy from Hold at Stifel... Helmerich & Payne (HP) upgraded to Overweight from Equal Weight at Stephens... Himax (HIMX) upgraded to Outperform from Neutral at Credit Suisse... Huntington Bancshares (HBAN) upgraded to Buy from Neutral at Guggenheim... InterContinental (IHG) upgraded to Outperform from Neutral at Credit Suisse... Knight Transportation (KNX) upgraded to Strong Buy on valuation at Raymond James... LogMeln (LOGM) upgraded to Overweight from Sector Weight at Pacific Crest... Patterson Companies (PDCO) upgraded to Overweight from Neutral at Piper Jaffray... Qunar (QUNR) upgraded on valuation, positive catalysts at Stifel... Regions Financial (RF) upgraded to Buy from Neutral at Guggenheim... Ryder (R) upgraded to Strong Buy from Outperform at Raymond James... SVB Financial (SIVB) upgraded to Buy from Neutral at DA Davidson... Seagate (STX) upgraded to Buy from Hold at Cross Research... Sinopec (SNP) upgraded to Neutral from Sell at Citi... Summit Hotel Properties (INN) upgraded to Outperform at Baird... Texas Capital (TCBI) upgraded to Buy from Neutral at DA Davidson... The Medicines Co. (MDCO) upgraded to Buy from Hold at Jefferies... U.S. Bancorp (USB) upgraded to Buy from Neutral at Guggenheim... Weatherford (WFT) upgraded to Overweight from Equal Weight at Stephens.
07:35 EDTGLNGGolar LNG upgraded on valuation, upcoming project completion at Stifel
Subscribe for More Information
06:21 EDTGLNGGolar LNG upgraded to Buy from Hold at Stifel
Subscribe for More Information
August 27, 2015
10:57 EDTPTCTOptions with increasing implied volatility
Subscribe for More Information
August 26, 2015
18:13 EDTGLNGGolar LNG sees shipping fleet utilizaton improving in Q3 vs. Q1
Golar reports that the lower gas price environment is triggering lower cost LNG production and the company believes this will create additional demand for the GoFLNG concept. A significant share of growth in the LNG market over the coming years is expected to come from LNG replacing coal and oil based power generation. The LNG shipping market remains under pressure and rates so far in 3Q have remained at levels around $25K-$30K per day. Utilization of the shipping fleet has however improved in Q3 versus Q1, the company added. The end of the commitment linked to Golar Eskimo and an improvement in utilization is likely to result in a solid improvement in Q2 operating results, according to the company.
18:10 EDTGLNGGolar LNG reports Q2 interim time and voyage charter revenues $16.92M
Subscribe for More Information
10:36 EDTPTCTOptions with increasing implied volatility
Options with increasing implied volatility: UVXY PTCT VIX SVXY SUNE SQQQ SPXS LPI
August 25, 2015
09:59 EDTPTCTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:01 EDTPTCTPTC Therapeutics initiated with a Buy at Citi
Subscribe for More Information
August 24, 2015
15:44 EDTPTCTOptions with increasing implied volatility
Subscribe for More Information
10:12 EDTPTCTOptions with increasing implied volatility
Subscribe for More Information
August 21, 2015
10:36 EDTPTCTOptions with increasing implied volatility
Options with increasing implied volatility: PTCT UVXY VIX VXX SVXXY SRPT TZA UPRO VNR SPXU
August 19, 2015
09:17 EDTPTCT'Female Viagra' approval seen as positive for Sarepta, BioMarin
The FDA's approval of the world's first drug designed to boost a woman's sexual desire is seen as boding well for companies awaiting critical decisions by the agency. FEMALE VIAGRA: The Food and Drug Administration yesterday approved flibanserin to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. The drug, which will be sold under the name "Addyi" and is commonly referred to as the "female Viagra," is the first FDA-approved treatment for sexual desire disorders in men or women, the agency prominently stated in its press release. HSDD is characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance, the FDA explained. Addyi was approved with a risk evaluation and mitigation strategy as well as a Boxed Warning given the risk of severe hypotension and syncope in patients who drink alcohol during treatment. The drug is made by privately held Sprout Pharmaceuticals. ANALYST REACTION: Addyi's approval is "another sign of flexibility" by the FDA, especially for first-in-class therapies, Roth Capital analyst Debjit Chattopadhyay writes this morning in a note to investors. This bodes well for the approval of eteplirsen, drisapersen and Translarna, the analyst contends. Eteplirsen, designed by Sarepta Therapeutics (SRPT), and drisapersen, designed by BioMarin (BMRN), are experimental drugs being developed to treat Duchenne muscular dystrophy. Translarna, designed by PTC Therapeutics (PTCT), is already being sold in Europe as a treatment for DMD and is awaiting approval from the FDA. Duchenne muscular dystrophy is a form of muscular dystrophy affecting around 1 in 3,600 boys, which results in muscle degeneration and premature death. SAVING LIVES: While female sexual dysfunction is a clinical problem, eteplirsen is designed to save lives, Chattopadhyay points out. He has a Buy rating on Sarepta and noted his price target of $45 assumes accelerated approval for eteplirsen in the first quarter of 2016. Shares of the Massachusetts-based biopharmaceutical company closed yesterday at $35.69.
08:29 EDTPTCTFlibanserin approval bodes well for Sarepta, others, says Roth Capital
Subscribe for More Information
August 18, 2015
07:03 EDTGLNGDynagas, GasLog, Golar LNG to establish, operate LNG Carrier Pool
Subscribe for More Information
07:02 EDTGLNGDynagas, GasLog, Golar enter LNG Carrier Pool agreement
Dynagas (DLNG), GasLog (GLOG), and Golar LNG (GLNG), jointly announce that they have entered into an LNG carrier pooling agreement to market their vessels, which are currently operating in the LNG shipping spot market. Tony Lauritzen has agreed to take overall responsibility for the running of The Cool Pool and Morten Nielsen has been appointed as Pool Manager, with the mandate to schedule employment for each pool vessel. The Cool Pool will focus exclusively on charters of 12 months duration or less. The scheduling of employment opportunities in excess of 12 months will remain the mandate of the respective vessel owner. If a pool vessel is scheduled by an owner for a charter that exceeds 12 months in duration such vessel will cease to form part of the LNG Carrier Pool's fleet. It is anticipated that The Cool Pool will commence operation in September 2015.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use